A B-type natriuretic peptide precursor of 28 pg/ml can rule out congestive heart failure, and generally does not require clinical treatment if there are no other cardiac complaints.
B-type natriuretic peptide precursor, which refers to NTpro-BNP, is synthesized and released in the heart.B-type natriuretic peptide possesses diuretic and antihypertensive effects, while B-type natriuretic peptide precursor is biologically inactive, and is often used as a test for heart failure.
The value of B-type natriuretic peptide precursor is affected by age, gender and renal function, the older the age, the higher the value of B-type natriuretic peptide precursor, and the value of patients with renal insufficiency is higher than that of patients with normal renal function.The B-type natriuretic peptide precursor can predict the risk of heart failure, and if the B-type natriuretic peptide precursor is <300pg/ml, the likelihood of congestive heart failure is lower.
If heart discomfort occurs, please go to the regular hospital in time to avoid delay.